Icahn turns up 'Rant' on Forest CEO's $500m stock sales
This article was originally published in Scrip
Executive Summary
The activist investor Carl Icahn, who has never let up on public criticism of the board of Forest Laboratories, has lobbed a new attack with the disclosure that he plans to probe disclosures that chief executive Howard Solomon made before selling stock in the drug maker over the years.